Loading company financials…
OTC MARKETS · Technology · CIK 0001520118
$0.2798
+17.02% · live
Updated
$1.8M market value
From MedWellAI, Inc.'s FY2026 10-K, filed Oct 13, 2026 · read the filing
MedWellAI lends money and provides credit. It took in $527.9K last year, which makes it a small company. It spends more than it earns — losing about 301 cents on every dollar of sales.
The filing does not provide enough evidence for a clear financial conclusion.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Significant financial weakness across most measures.
From MedWellAI, Inc.'s FY2026 annual filing · share price scored separately
Largest year-over-year changes in FY2026
Operating income
-$2.8M → -$1.2M
Profit
-$3.6M → -$1.6M
Operating margin
-477.6% → -234.2%
Profit margin
-606.5% → -301.1%
Measured against FY2025, from the 10-K filed Oct 13, 2026
Improved: $1.6M narrower
-$2.8M to -$1.2MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: $2.0M narrower
-$3.6M to -$1.6MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote live), and what was published around it
MWAI rose 17.02% on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −1.04%. That is 15.9 points above its sector and 18.1 points above the market.
No filing from MWAI and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 0.0% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $1.6M last year, losing about 301 cents on every dollar of sales.
No. Sales shrank 11.2% last year.
For every $1 it owes, it owns $0.02 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors. Its operating profit does not cover its interest bill — -23.63x against the interest it owes.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2026 annual filing
Last year it lost $1.6M and generated -$307.0K of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202610-K · Oct 13, 2026Filing for FY2026 | FY202510-K · Oct 13, 2026Filing for FY2025 | FY202410-K · Sep 30, 2025Filing for FY2024 | FY202310-K · Sep 30, 2024Filing for FY2023 | FY202210-K/A · Sep 28, 2023Filing for FY2022 | ChangeFY2026 vs FY2025 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $527.9K | $594.8K | $0.00 | $3.9M | $6.6M | −11.2% |
| Cost of revenue | — | — | $3.9M | $2.7M | $3.9M | — |
| Gross profit | — | — | -$3.9M† | -$2.4M | $2.7M | — |
| Gross marginGross profit ÷ revenueWhat is this? | — | — | — | -63.0% | 40.9% | — |
| Selling, general and administrative | $1.7M | $2.6M | $9.3M | $16.0M | $3.2M | −36.6% |
| Operating income | -$1.2M | -$2.8M | -$9.1M | -$25.2M | -$688.0K | +56.5% |
| Operating marginOperating income ÷ revenueWhat is this? | -234.2% | -477.6% | — | -651.6% | -10.5% | +243.3 pts |
| Interest expense | $52.3K | $52.2K | $83.0K | $276.9K | $18.3K | +0.2% |
| Income before tax | -$1.5M | -$2.9M | -$9.2M | -$25.5M | -$565.5K | +48.5% |
| Net income | -$1.6M | -$3.6M | -$11.5M | -$25.5M | -$565.5K | +55.9% |
| Net marginNet income ÷ revenueWhat is this? | -301.1% | -606.5% | — | -659.1% | -8.6% | +305.4 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-0.2432 | $-0.5831 | $-2.28 | $-8.89 | $-0.3411 | +58.3% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Nothing recent
No insider trades, pending-sale notices or 5% stake filings from MWAI in the last few months. That is the ordinary case, not a gap.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Annual report for FY2026
Revenue -11.2% · Operating margin +243.3 pts · Operating income $1.6M narrower — against FY2025
Read the filingQuarterly report for Q3 FY2026
Revenue +119.9% · Operating margin +252.6 pts · Operating income $586.3K narrower — against Q3 FY2025
Read the filingWrite down why you are following MedWellAI, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update
Yahoo Finance ·
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
Yahoo Finance ·
MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000
Yahoo Finance ·
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
Yahoo Finance ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from MWAI's 10-K for fiscal year 2026 (period ending 2026-06-30, filed Oct 13, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2026 | 2.0 | 3/7 | 10-K, filed Oct 13, 2026 |
| FY2025 | 2.0 | 3/7 | 10-K, filed Sep 30, 2025 |
| FY2024 | 4.7 | 5/8 | 10-K, filed Sep 30, 2024 |
| FY2023 | 2.0 | 2/8 | 10-K, filed Sep 28, 2023 |
| FY2022 | 4.7 | 4/8 | 10-K, filed Sep 28, 2022 |
| FY2021 | 4.7 | 3/8 | 10-K, filed Sep 24, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
3 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2026 filing as filed with the SEC.
Improved: +243.3 pts
-477.6% to -234.2%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +305.4 pts
-606.5% to -301.1%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: $543.7K narrower
-$850.8K to -$307.0KCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: $0.34 narrower
-$0.58 to -$0.24Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -78.5%
$401.3K to $86.2KCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: turned negative
$2.2K to $0.00Critical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: +5.7%
6.2M to 6.5MSignificant
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Deteriorated: -11.2%
$594.8K to $527.9KNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
Amended its charter or changed its financial year
Read the filingQuarterly report for Q2 FY2026
Revenue +283.8% · Operating margin +170.6 pts · Profit $386.4K narrower — against Q2 FY2025
Read the filingQuarterly report for Q1 FY2026
Revenue +8270.6% · Operating margin +50965.9 pts · Operating income $262.9K narrower — against Q1 FY2025
Read the filingAnnual report for FY2025
Revenue turned positive · Operating income $6.2M narrower · Profit $7.9M narrower — against FY2024
Read the filingChanged the rights attached to its shares · Amended its charter or changed its financial year · Reported another event
Read the filingAmended its charter or changed its financial year · Reported another event
Read the filingQuarterly report for Q3 FY2025
Revenue -85.8% · Operating margin −305.6 pts · Gross profit -64.2% — against Q3 FY2024
Read the filingQuarterly report for Q2 FY2025
Revenue -91.7% · Operating margin −201.1 pts · Gross profit turned positive — against Q2 FY2024
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q1 FY2025
Read the filingAnnual report for FY2024
Revenue turned negative · Gross profit $1.5M wider · Operating income $16.1M narrower — against FY2023
Read the filingSigned a material agreement · Completed an acquisition or disposal
Read the filingQuarterly report for Q3 FY2024
Read the filingAnnual report for FY2023
Revenue -41.0% · Operating margin −641.1 pts · Gross profit turned negative — against FY2022
Read the filingQuarterly report for Q2 FY2024
Read the filingQuarterly report on Form 10-Q
Read the filingAnnual report for FY2023
Revenue -41.0% · Operating margin −641.1 pts · Gross profit turned negative — against FY2022
Read the filingQuarterly report on Form 10-Q
Read the filingApollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.
Yahoo Finance ·
Primary sources and further research